First AI-Designed Phage Therapy Administered to Patient with Resistant Superbug

A startup reports the first administration of an AI-designed bacteriophage to a patient with a drug-resistant infection and no remaining treatment options. The claim is based on a single case report, with efficacy and safety unverified. This marks a novel application of AI in personalized medicine, potentially expanding therapeutic options against antimicrobial resistance.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works